Cargando…
In silico SNP analysis of the breast cancer antigen NY-BR-1
BACKGROUND: Breast cancer is one of the most common malignancies with increasing incidences every year and a leading cause of death among women. Although early stage breast cancer can be effectively treated, there are limited numbers of treatment options available for patients with advanced and meta...
Autores principales: | Kosaloglu, Zeynep, Bitzer, Julia, Halama, Niels, Huang, Zhiqin, Zapatka, Marc, Schneeweiss, Andreas, Jäger, Dirk, Zörnig, Inka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116164/ https://www.ncbi.nlm.nih.gov/pubmed/27863482 http://dx.doi.org/10.1186/s12885-016-2924-7 |
Ejemplares similares
-
A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic mice
por: Das, Krishna, et al.
Publicado: (2019) -
Multiplex bead-based measurement of humoral immune responses against tumor-associated antigens in stage II melanoma patients of the EORTC18961 trial
por: Michels, Judith, et al.
Publicado: (2018) -
Tertiary lymphoid structures and their association to immune phenotypes and circulatory IL2 levels in pancreatic ductal adenocarcinoma
por: Ahmed, Azaz, et al.
Publicado: (2022) -
Predictive Immunological Markers in Oncology
por: Jäger, Dirk, et al.
Publicado: (2012) -
Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications
por: Balafoutas, Dimitrios, et al.
Publicado: (2013)